WO2008143280A1 - 鎮静剤 - Google Patents

鎮静剤 Download PDF

Info

Publication number
WO2008143280A1
WO2008143280A1 PCT/JP2008/059326 JP2008059326W WO2008143280A1 WO 2008143280 A1 WO2008143280 A1 WO 2008143280A1 JP 2008059326 W JP2008059326 W JP 2008059326W WO 2008143280 A1 WO2008143280 A1 WO 2008143280A1
Authority
WO
WIPO (PCT)
Prior art keywords
histidine
sedative
agent
sedative agent
dipeptide
Prior art date
Application number
PCT/JP2008/059326
Other languages
English (en)
French (fr)
Inventor
Mitsuhiro Furuse
Yousuke Tsuneyoshi
Koji Morishita
Original Assignee
Kyowa Hakko Bio Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Bio Co., Ltd. filed Critical Kyowa Hakko Bio Co., Ltd.
Publication of WO2008143280A1 publication Critical patent/WO2008143280A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

　副作用を示すことなく効果的に鎮静作用を示す医薬品、機能性食品等の開発が望まれている。 　本発明により、イソロイシルヒスチジン、バリルヒスチジン、セリルヒスチジンおよびヒスチジルβ－アラニンからなる群から選ばれる１以上のジペプチドまたはその塩を有効成分として含有する鎮静剤を提供することができる。
PCT/JP2008/059326 2007-05-21 2008-05-21 鎮静剤 WO2008143280A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007134248 2007-05-21
JP2007-134248 2007-05-21

Publications (1)

Publication Number Publication Date
WO2008143280A1 true WO2008143280A1 (ja) 2008-11-27

Family

ID=40031975

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059326 WO2008143280A1 (ja) 2007-05-21 2008-05-21 鎮静剤

Country Status (1)

Country Link
WO (1) WO2008143280A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010087480A1 (ja) * 2009-02-02 2010-08-05 国立大学法人京都大学 ペプチドを含む医薬または食品
JP2014080420A (ja) * 2012-09-28 2014-05-08 Saga Univ 抗真菌性を有するアミノ酸誘導体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452744A (en) * 1987-08-24 1989-02-28 Nippon Zoki Pharmaceutical Co Novel peptide compound and production thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452744A (en) * 1987-08-24 1989-02-28 Nippon Zoki Pharmaceutical Co Novel peptide compound and production thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
USAMI N. ET AL.: "Histidine Kanren Dipeptide no Suimin Sokushin Sayo no Umu no Kento", THE PHARMACEUTICAL SOCIETY OF JAPAN DAI 127 NENKAI YOSHISHU, 5 March 2007 (2007-03-05), pages 130 + ABSTR. NO. 28P2-AM122 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010087480A1 (ja) * 2009-02-02 2010-08-05 国立大学法人京都大学 ペプチドを含む医薬または食品
JP2014080420A (ja) * 2012-09-28 2014-05-08 Saga Univ 抗真菌性を有するアミノ酸誘導体

Similar Documents

Publication Publication Date Title
IL204079A (en) Pesticide exterminators and methods of increasing the effectiveness of active material exterminate pests
ZA200902632B (en) Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
EP2055314A4 (en) ACTIVATOR WITH A BIOTENSID AS ACTIVE AGENT, MANNOSYLERYTHRITOL LIPID AND METHOD OF MANUFACTURING THEREOF
WO2007127158A3 (en) Modification of percutaneous absorption of topically active materials
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2009117130A3 (en) Extended release forumulation containing a wax
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2010111640A3 (en) Anti-influenza formulations and methods
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
WO2011117272A3 (en) Pesticidal mixtures
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
ZA200903547B (en) Insecticidal active ingredient combinations (formononetins + insecticides)
WO2010021607A3 (en) Pharmaceutical formulation
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE
WO2012000946A3 (de) Synergistische wirkstoffkombinationen enthaltend penflufen
EP1961764A4 (en) SUGAR CHAIN AND PEPTIDE ADDITION PRODUCT AND PHARMACEUTICAL PRODUCT COMPRISING SAID PRODUCT AS ACTIVE INGREDIENT
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
WO2008003050A3 (en) Gallium nitrate formulations
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
EP2801358A3 (en) The use of nicotine for diminishing pain in renal region in humans

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08764449

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08764449

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP